Intravenous Crystalloid
Drugcrystalloid is administered to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture
NCT Number: NCT02700607
After obtaining approval from the Institutional Review Board of our institution, written informed consent is obtained from patients undergoing interventional cerebral aneurysm coiling procedure are enrolled in this prospective study and randomly allocated into one of two groups: Group-C (n=15) and Group-HES (n=15).
All recruited patients will be given patient identification number (PIN) for the present study of 01-30 according to their order of interview and recruitment. Investigators will prepare 15 yellow and 15 green cards, which will be inserted in 20 thick-paper envelopes. Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 30 (Envelop number). After printing the envelope number outside envelope, all sealed envelopes with cards will be conveyed to and kept in pharmacy department.
According to the color of the card, attending anesthesiologists will give crystalloid for yellow card or HES for green cards, respectively, to maintain stroke volume variation lesser than 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture.
Patient data and statistical analyses:
Patients demographic data, whole blood viscosity, PaO2, FiO2, Hemoglobin, urine amount, s-glucose will be obtained
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
crystalloid is administered to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture
HES is administered to maintain stroke volume variation < 15 during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture
Time frame: with 1 hour after the completion of procedure
whole blood viscosity measured by viscometer cm-1
Time frame: 1 hour after the completion of procedure
PaO2/FiO2 ratio measured by arterial blood gas analysis
Time frame: 1 hour after the completion of procedure
serum hematocrit, %
Time frame: 1 hour after the completion of procedure
serum glucose level, g/dl
Time frame: 1 hour after the completion of procedure
serum osmolarity, mosm
Time frame: 1 hour after the completion of procedure
hourly urine output, ml/hr
Konkuk University Medical Center
Other
Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Coiling Embolization Procedure for Cerebral Artery Aneurysm
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05774782
Aneurysm, Brain Diseases
Beijing, China
View Trial DetailsNCT05945563
Aneurysm, Brain Diseases
Dallas, Texas, United States
View Trial DetailsNCT01655784
Aneurysm, Brain Diseases
Fresno, California, United States
View Trial DetailsNCT00614887
Aneurysm, Brain Diseases
Kuopio, PL 1777, Finland
View Trial Details